142 related articles for article (PubMed ID: 18038871)
21. Early referral to a palliative team improves end-of-life care among gynecological cancer patients: a retrospective, population-based study.
Paulsen T; Liland H; Myklebust TÅ; Lindemann K
Int J Gynecol Cancer; 2022 Feb; 32(2):181-188. PubMed ID: 34987096
[TBL] [Abstract][Full Text] [Related]
22. End-of-life care for lung cancer patients in the United States and Ontario.
Warren JL; Barbera L; Bremner KE; Yabroff KR; Hoch JS; Barrett MJ; Luo J; Krahn MD
J Natl Cancer Inst; 2011 Jun; 103(11):853-62. PubMed ID: 21593012
[TBL] [Abstract][Full Text] [Related]
23. Patient Burden and Real-World Management of Chemotherapy-Induced Myelosuppression: Results from an Online Survey of Patients with Solid Tumors.
Epstein RS; Aapro MS; Basu Roy UK; Salimi T; Krenitsky J; Leone-Perkins ML; Girman C; Schlusser C; Crawford J
Adv Ther; 2020 Aug; 37(8):3606-3618. PubMed ID: 32642965
[TBL] [Abstract][Full Text] [Related]
24. Risk of treatment related death and febrile neutropaenia with first line palliative chemotherapy for de novo metastatic breast cancer in clinical practice in a middle resource country.
Phua CE; Tang WH; Yusof MM; Saad M; Alip A; See MH; Taib NA
Asian Pac J Cancer Prev; 2014; 15(23):10263-6. PubMed ID: 25556458
[TBL] [Abstract][Full Text] [Related]
25. Effect of early palliative care on chemotherapy use and end-of-life care in patients with metastatic non-small-cell lung cancer.
Greer JA; Pirl WF; Jackson VA; Muzikansky A; Lennes IT; Heist RS; Gallagher ER; Temel JS
J Clin Oncol; 2012 Feb; 30(4):394-400. PubMed ID: 22203758
[TBL] [Abstract][Full Text] [Related]
26. Chemotherapy given near the end of life by community oncologists for advanced non-small cell lung cancer.
Murillo JR; Koeller J
Oncologist; 2006; 11(10):1095-9. PubMed ID: 17110629
[TBL] [Abstract][Full Text] [Related]
27. Trends in treatment during the last stages of life in end-stage gynecologic cancer patients who received active palliative chemotherapy: a comparative analysis of 10-year data in a single institution.
Jang TK; Kim DY; Lee SW; Park JY; Suh DS; Kim JH; Kim YM; Kim YT; Nam JH
BMC Palliat Care; 2018 Aug; 17(1):99. PubMed ID: 30086748
[TBL] [Abstract][Full Text] [Related]
28. Trends in End-of-Life Care in Pediatric Hematology, Oncology, and Stem Cell Transplant Patients.
Brock KE; Steineck A; Twist CJ
Pediatr Blood Cancer; 2016 Mar; 63(3):516-22. PubMed ID: 26513237
[TBL] [Abstract][Full Text] [Related]
29. Outpatient Palliative Care and Aggressiveness of End-of-Life Care in Patients with Metastatic Colorectal Cancer.
Lee SW; Jho HJ; Baek JY; Shim EK; Kim HM; Ku JY; Nam EJ; Chang YJ; Choi HJ; Kim SY
Am J Hosp Palliat Care; 2018 Jan; 35(1):166-172. PubMed ID: 28100061
[TBL] [Abstract][Full Text] [Related]
30. The last 3 months of life of cancer patients: medical aspects and role of home-care services in southern Switzerland.
Sessa C; Roggero E; Pampallona S; Regazzoni S; Ghielmini M; Lang M; Marx B; Neuenschwander H; Pagani O; Vasilievic V; Cavalli F
Support Care Cancer; 1996 May; 4(3):180-5. PubMed ID: 8739649
[TBL] [Abstract][Full Text] [Related]
31. Reduced-dose combination chemotherapy (S-1 plus oxaliplatin) versus full-dose monotherapy (S-1) in older vulnerable patients with metastatic colorectal cancer (NORDIC9): a randomised, open-label phase 2 trial.
Winther SB; Liposits G; Skuladottir H; Hofsli E; Shah CH; Poulsen LØ; Ryg J; Osterlund P; Berglund Å; Qvortrup C; Glimelius B; Sorbye H; Pfeiffer P
Lancet Gastroenterol Hepatol; 2019 May; 4(5):376-388. PubMed ID: 30852136
[TBL] [Abstract][Full Text] [Related]
32. Trends in the place of death of cancer patients, 1992-1997.
Burge F; Lawson B; Johnston G
CMAJ; 2003 Feb; 168(3):265-70. PubMed ID: 12566330
[TBL] [Abstract][Full Text] [Related]
33. [Accessibility of home palliative care and place of death of cancer patients: data analysis of the Emilia-Romagna Region.].
Martoni AA; Strocchi E
Recenti Prog Med; 2018 Mar; 109(3):185-192. PubMed ID: 29565052
[TBL] [Abstract][Full Text] [Related]
34. The facilitating role of chemotherapy in the palliative phase of cancer: qualitative interviews with advanced cancer patients.
Buiting HM; Terpstra W; Dalhuisen F; Gunnink-Boonstra N; Sonke GS; den Hartogh G
PLoS One; 2013; 8(11):e77959. PubMed ID: 24223130
[TBL] [Abstract][Full Text] [Related]
35. National Trends in End-of-Life Care for Veterans With Advanced Cancer in the Veterans Health Administration: 2009 to 2016.
Smith CEP; Kamal AH; Kluger M; Coke P; Kelley MJ
J Oncol Pract; 2019 Jun; 15(6):e568-e575. PubMed ID: 31046573
[TBL] [Abstract][Full Text] [Related]
36. Chemotherapy Near the End of Life in Onco-Hematological Adult Patients.
Sánchez-Cuervo M; García-Basas L; Gómez de Salazar-López de Silanes E; Pueyo-López C; Bermejo-Vicedo T
Am J Hosp Palliat Care; 2020 Aug; 37(8):641-647. PubMed ID: 31968989
[TBL] [Abstract][Full Text] [Related]
37. End-of-life care discussions among patients with advanced cancer: a cohort study.
Mack JW; Cronin A; Taback N; Huskamp HA; Keating NL; Malin JL; Earle CC; Weeks JC
Ann Intern Med; 2012 Feb; 156(3):204-10. PubMed ID: 22312140
[TBL] [Abstract][Full Text] [Related]
38. [Chemotherapy at the end of life: Uncommon clinical practice?].
Santos Pérez MI; Godoy Díez M; Abajo Del Álamo C
J Healthc Qual Res; 2019; 34(4):201-207. PubMed ID: 31713531
[TBL] [Abstract][Full Text] [Related]
39. Associations between end-of-life discussion characteristics and care received near death: a prospective cohort study.
Mack JW; Cronin A; Keating NL; Taback N; Huskamp HA; Malin JL; Earle CC; Weeks JC
J Clin Oncol; 2012 Dec; 30(35):4387-95. PubMed ID: 23150700
[TBL] [Abstract][Full Text] [Related]
40. [Chemotherapy at the end of life is compatible with dignified death and palliative care].
Diaz MH; Ibañez Ledesma LG; Torres Gomez F; Carretero M; Pasquinelli R; Martínez BJ; Grande Ratti MF
Rev Fac Cien Med Univ Nac Cordoba; 2023 Jun; 80(2):93-98. PubMed ID: 37402305
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
